Potassium channels and pain: Present realities and future opportunities

European Journal of Pharmacology

Volumn 500, Issue 1-3 SPEC. ISS., 2004, Pages 203-219

  Ocaña, María ^a   Cendán, Cruz Miguel ^a   Cobos, Enrique José ^a   Entrena, José Manuel ^a   Baeyens, José Manuel ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Antinociception; G protein coupled receptor; K + channels; Nonsteroidal antiinflammatory drugs; Opioid; Tricyclic antidepressant

Indexed keywords

ADENOSINE A1 RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; APAMIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; CANNABINOID RECEPTOR; DELTA OPIATE RECEPTOR; DIAZOXIDE; DIBUTYRYL CYCLIC GMP; DICLOFENAC; DIPYRONE; DOPAMINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; GLIBENCLAMIDE; GLIQUIDONE; INDOMETACIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; KETOROLAC; MEMBRANE PROTEIN; MEPYRAMINE; MINOXIDIL; MU OPIATE RECEPTOR; NATURAL PRODUCT; NITROPRUSSIDE SODIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PINACIDIL; POTASSIUM CHANNEL; ROFECOXIB; SEROTONIN 1A RECEPTOR; SULFONYLUREA; TANDEM PORE DOMAIN POTASSIUM CHANNEL; TETRYLAMMONIUM; TOLBUTAMIDE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANTINOCICEPTION; DRUG EFFECT; DRUG MECHANISM; HUMAN; HYPERALGESIA; NONHUMAN; PAIN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW;

ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; CLINICAL TRIALS; HUMANS; ION CHANNEL GATING; PAIN; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, OPIOID;

EID: 4644237028     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.07.026     Document Type: Review

References (90)

1. ATP channels Physiol. Rev. 78 1998 227 245
2. + channels in the peripheral antinociceptive effect induced by dipyrone Eur. J. Pharmacol. 444 2002 47 52
3. + channels, and sodium nitroprusside and dibutyryl-cGMP Eur. J. Pharmacol. 489 2004 59 65
4. + channels activation Life Sci. 74 2004 2577 2591
5. + channels Science 247 1990 852 854
6. 2-adrenergic agonist in rats Anesth. Analg. 90 2000 1146 1151
7. A. Beirith, A.R. Santos, A.L. Rodrigues, T.B. Creczynski-Pasa, and J.B. Calixto Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action Eur. J. Pharmacol. 345 1998 233 245
8. G. Blackburn-Munro, and B.S. Jensen The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain Eur. J. Pharmacol. 460 2003 109 116
9. Y.A. Blednov, M. Stoffel, H. Alva, and R.A. Harris A pervasive mechanism for analgesia: activation of GIRK2 channels Proc. Natl. Acad. Sci. U. S. A. 100 2003 277 282
10. V.C. Campbell, and S.P. Welch The role of minoxidil on endogenous opioid peptides in the spinal cord: a putative co-agonist relationship between K-ATP openers and opioids Eur. J. Pharmacol. 417 2001 91 98
11. J.D. Clark, and B.L. Tempel Hyperalgesia in mice lacking the Kv1.1 potassium channel gene Neurosci. Lett. 251 1998 121 124
12. + channel cascade in the antinociceptive effect of rofecoxib Eur. J. Pharmacol. 484 2004 193 199
13. R. Dost, A. Rostock, and C. Rundfeldt The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activation Naunyn- Schmiedeberg's Arch. Pharmacol. 369 2004 382 390
14. + channel KCNK5 (TASK-2) in the rat central nervous system Mol. Brain Res. 98 2002 153 163
15. + channel Eur. J. Pharmacol. 330 1997 15 25
16. N. Galeotti, C. Ghelardini, L. Papucci, S. Capaccioli, A. Quattrone, and A. Bartolini An antisense oligonucleotide on the mouse Shaker-like potassium channel Kv1.1 gene prevents antinociception induced by morphine and baclofen J. Pharmacol. Exp. Ther. 281 1997 941 949
17. N. Galeotti, C. Ghelardini, and A. Bartolini The role of potassium channels in antihistamine analgesia Neuropharmacology 38 1999 1893 1901
18. 2-adrenoceptors Br. J. Pharmacol. 126 1999 1214 1220
19. N. Galeotti, C. Ghelardini, and A. Bartolini Involvement of potassium channels in amitriptyline and clomipramine analgesia Neuropharmacology 40 2001 75 84
20. V. Granados-Soto, C.F. Argúelles, and M.I. Ortiz The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels Neuropharmacology 43 2002 917 923
21. V.K. Gribkoff The therapeutic potential of neuronal KCNQ channel modulators Expert Opin. Ther. Targets 7 2003 737 748
22. G.A. Gutman, K.G. Chandy, J.P. Adelman, J. Aiyar, D.A. Bayliss, D.E. Clapham, M. Covarriubias, G.V. Desir, K. Furuichi, B. Ganetzky, M.L. Garcia, S. Grissmer, L.Y. Jan, A. Karschin, D. Kim, S. Kuperschmidt, Y. Kurachi, M. Lazdunski, F. Lesage, H.A. Lester, D. McKinnon, C.G. Nichols, I. O'Kelly, J. Robbins, G.A. Robertson, B. Rudy, M. Sanguinetti, S. Seino, W. Stuehmer, M.M. Tamkun, C.A. Vandenberg, A. Wei, H. Wulff, and R.S. Wymore International Union of Pharmacology: XLI. Compendium of voltage-gated ion channels: potassium channels Pharmacol. Rev. 55 2003 583 586
23. W.M. Hu, Y.M. Kang, and J.T. Qiao Involvement of endogenous opioids and ATP-sensitive potassium channels in the mediation of apomorphine-induced antinociception at the spinal level: a study using EMG planimetry of flexor reflex in rats Brain Res. Bull. 48 1999 315 318
24. + (GIRK) channels in opioid-induced analgesia Neurosci. Res. 38 2000 113 116
25. W. Janson, and C. Stein Peripheral opioid analgesia Curr. Pharm. Biotechnol. 4 2003 270 274
26. G.J. Kaczorowski, and M.L. Garcia Pharmacology of voltage-gated and calcium-activated potassium channels Curr. Opin. Chem. Biol. 3 1999 448 458
27. J. Kamei, N. Kawashima, M. Narita, T. Suzuki, M. Misawa, and Y. Kasuya Reduction in ATP-sensitive potassium channel-mediated antinociception in diabetic mice Psychopharmacology 113 1994 318 321
28. Y. Kang, C. Zhang, and J. Qiao Involvement of endogenous opioids and ATP-sensitive potassium channels in the mediation of carbachol-induced antinociception at the spinal level: a behavioral study in rats Brain Res. 761 1997 342 346
29. Y.M. Kang, W.M. Hu, and J.T. Qiao Endogenous opioids and ATP-sensitive potassium channels are involved in the mediation of apomorphine-induced antinociception at the spinal level: a behavioral study in rats Brain Res. Bull. 46 1998 225 228
30. + channels are involved in the mediation of intrathecal norepinephrine- or morphine-induced antinociception at the spinal level: a study using EMG planimetry of flexor reflex in rats Brain Res. Bull. 45 1998 269 273
31. + channels Trends Pharmacol. Sci. 24 2003 648 654
32. + channel pathway in the antinociceptive action of ketorolac Eur. J. Pharmacol. 426 2001 39 44
33. J.F. Liegeois, F. Mercier, A. Graulich, F. Graulich-Lorge, J. Scuvee-Moreau, and V. Seutin Modulation of small conductance calcium-activated potassium (SK) channels: a new challenge in medicinal chemistry Curr. Med. Chem. 10 2003 625 647
34. + channel opener-induced antinociception Eur. J. Pharmacol. 384 1999 147 152
35. + channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides Eur. J. Pharmacol. 385 1999 119 127
36. R. MacKinnon Potassium channels FEBS Lett. 555 2003 62 65
37. + channels Eur. J. Biochem. 267 2000 5830 5836
38. C.L. Marker, S.C. Cintora, M.I. Roman, M. Stoffel, and K. Wickman Hyperalgesia and blunted morphine analgesia in G protein-gated potassium channel subunit knockout mice NeuroReport 13 2002 2509 2513
39. + channels formed by GIRK1 and GIRK2 subunits modulate thermal nociception and contribute to morphine analgesia J. Neurosci. 24 2004 2806 2812
40. A. Mathie, J.R. Wooltorton, and C.S. Watkins Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents Gen. Pharmacol. 30 1998 13 24
41. G.L. Mendes, A.R. Santos, A. Malheiros, V.C. Filho, R.A. Yunes, and J.B. Calixto Assessment of mechanisms involved in antinociception caused by sesquiterpene polygodial J. Pharmacol. Exp. Ther. 292 2000 164 172
42. 2-adrenergic analgesia and analgesic sex differences Proc. Natl. Acad. Sci. U. S. A. 100 2003 271 276
43. + channel modulators on the antiallodynic effect of gabapentin Eur. J. Pharmacol. 484 2004 201 208
44. A. Nardi, V. Calderone, S. Chericoni, and I. Morelli Natural modulators of large-conductance calcium-activated potassium channels Planta Med. 69 2003 885 892
45. M. Narita, T. Suzuki, M. Misawa, H. Nagase, A. Nabeshima, T. Ashizawa, H. Ozawa, T. Saito, and N. Takahata Role of central ATP-sensitive potassium channels in the analgesic effect and spinal noradrenaline turnover-enhancing effect of intracerebroventricularly injected morphine in mice Brain Res. 596 1992 209 214
46. M. Narita, K. Takamori, N. Kawashima, M. Funada, J. Kamei, T. Suzuki, M. Misawa, and H. Nagase Activation of central ATP-sensitive potassium channels produces the antinociception and spinal noradrenaline turnover-enhancing effect in mice Psychopharmacology 113 1993 11 14
47. C.G. Nichols, and A.N. Lopatin Inward rectifier potassium channels Annu. Rev. Physiol. 59 1997 171 191
48. A.N. Nielsen, C. Mathiesen, and G. Blackburn-Munro Pharmacological characterisation of acid-induced muscle allodynia in rats Eur. J. Pharmacol. 487 2004 93 103
49. R.A. North Drug receptors and the inhibition of nerve cells Br. J. Pharmacol. 98 1989 13 28
50. B and κ-opioid receptor agonists Br. J. Pharmacol. 110 1993 1049 1054
51. 1 receptor agonist Naunyn-Schmiedeberg's Arch. Pharmacol. 350 1994 57 62
52. M. Ocaña, E. Del Pozo, M. Barrios, L.I. Robles, and J.M. Baeyens An ATP-dependent potassium channel blocker antagonizes morphine analgesia Eur. J. Pharmacol. 186 1990 377 378
53. + channel blockers antagonize morphine- but not U-504,88H-induced antinociception Eur. J. Pharmacol. 230 1993 203 207
54. + channel-acting drugs Br. J. Pharmacol. 114 1995 1296 1302
55. B, mu and kappa opioid receptors J. Pharmacol. Exp. Ther. 276 1996 1136 1142
56. + channels by novel benzimidazolone Eur. J. Pharmacol. 251 1994 53 59
57. + channels by diclofenac Eur. J. Pharmacol. 438 2002 85 91
58. + channels Pharmacol. Biochem. Behav. 74 2003 465 470
59. + channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin Pharmacol. Biochem. Behav. 76 2003 187 195
60. G.M. Passmore, A.A. Selyanko, M. Mistry, M. Al Qatari, S.J. Marsh, E.A. Matthews, A.H. Dickenson, T.A. Brown, S.A. Burbidge, M. Main, and D.A. Brown KCNQ/M currents in sensory neurons: significance for pain therapy J. Neurosci. 23 2003 7227 7236
61. G.W. Pasternak Insights into mu opioid pharmacology: the role of mu opioid receptor subtypes Life Sci. 68 2001 2213 2219
62. + channels mediates the antinociceptive effect of Crotalus durissus terrificus snake venom Eur. J. Pharmacol. 469 2003 57 64
63. R.M. Quock, T.H. Burkey, E. Varga, Y. Hosohata, K. Hosohata, S.M. Cowell, C.A. Slate, F.J. Ehlert, W.R. Roeske, and H.I. Yamamura The δ-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy Pharmacol. Rev. 51 1999 503 532
64. + channels Brain Res. 650 1994 146 148
65. R.B. Raffa, and R.P. Martinez The 'glibenclamide-shift' of centrally-acting antinociceptive agents in mice Brain Res. 677 1995 277 282
66. M.N. Rasband, E.W. Park, T.W. Vanderah, J. Lai, F. Porreca, and J.S. Trimmer Distinct potassium channels on pain-sensing neurons Proc. Natl. Acad. Sci. U. S. A. 98 2001 13373 13378
67. D.S. Roane, and N.E. Boyd Reduction of food intake and morphine analgesia by central glybenclamide Pharmacol. Biochem. Behav. 46 1993 205 207
68. 1A receptors Eur. J. Pharmacol. 295 1996 181 188
69. + channels Br. J. Pharmacol. 129 2000 110 114
70. +-channel flux: a structural perspective Trends Biochem. Sci. 29 2004 39 45
71. + channels by GTP-binding proteins in a mammalian cell line J. Physiol. 507 1998 315 324
72. + channels and Gi/o protein in the antinociceptive action of the gallic acid ethyl ester Eur. J. Pharmacol. 379 1999 7 17
73. A.R. Santos, A.P. Trentin, J. Ferreira, R.A. Yunes, and J.B. Calixto Mechanisms involved in the antinociception caused by compound MV8612 isolated from Mandevilla velutina in mice Brain Res. 961 2003 269 276
74. + channels and block neurosecretion Proc. Natl. Acad. Sci. U. S. A. 87 1990 3489 3492
75. +-channels in homotaurine-induced analgesia Fundam. Clin. Pharmacol. 15 2001 167 173
76. Y.S. Shiau, P.T. Huang, H.H. Liou, Y.C. Liaw, Y.Y. Shiau, and K.L. Lou Structural basis of binding and inhibition of novel tarantula toxins in mammalian voltage-dependent potassium channels Chem. Res. Toxicol. 16 2003 1217 1225
77. C.C. Shieh, M. Coghlan, J.P. Sullivan, and M. Gopalakrishnan Potassium channels: molecular defects, diseases, and therapeutic opportunities Pharmacol. Rev. 52 2000 557 594
78. 2-induced hyperalgesic paw Br. J. Pharmacol. 134 2001 127 131
79. + channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside Eur. J. Pharmacol. 400 2000 67 71
80. C. Vergara, R. Latorre, N.V. Marrion, and J.P. Adelman Calcium-activated potassium channels Curr. Opin. Neurobiol. 8 1998 321 329
81. A.V. Vergoni, A. Scarano, and A. Bertolini Pinacidil potentiates morphine analgesia Life Sci. 50 1992 L135 L138
82. F. Vogalis, J.F. Storm, and B. Lancaster SK channels and the varieties of slow after-hyperpolarizations in neurons Eur. J. Neurosci. 18 2003 3155 3166
83. + channels by G-protein βγ-subunits EMBO J. 19 2000 4915 4925
84. S.P. Welch, and L.D. Dunlow Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action? J. Pharmacol. Exp. Ther. 267 1993 390 399
85. 9-THC-induced antinociception J. Pharmacol. Exp. Ther. 273 1995 1235 1244
86. S.P. Welch, C. Thomas, and G.S. Patrick Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine J. Pharmacol. Exp. Ther. 272 1995 310 321
87. K.D. Wild, T. Vanderah, H.I. Mosberg, and F. Porreca Opioid δ receptor subtypes are associated with different potassium channels Eur. J. Pharmacol. 193 1991 135 136
88. I. Yamazumi, T. Okuda, and Y. Koga Involvement of potassium channels in spinal antinociceptions induced by fentanyl, clonidine and bethanechol in rats Jpn. J. Pharmacol. 87 2001 268 276
89. S.W. Yang, Y.M. Kang, Y.Q. Guo, J.T. Qiao, and N. Dafny ATP-sensitive potassium channels mediate norepinephrine- and morphine-induced antinociception at the spinal cord level Int. J. Neurosci. 93 1998 217 223
90. K. Zushida, K. Onodera, and J. Kamei Effect of diabetes on pinacidil-induced antinociception in mice Eur. J. Pharmacol. 453 2004 209 215